95 related articles for article (PubMed ID: 3591061)
1. [Behavior of some tumor markers (secretory immunoglobulin A, pregnancy-associated alpha 2-glycoprotein, circulating immune complexes in the serum of patients with breast tumors].
Briese V; Strache RR; Büttner HH; Kunze M; Brock J; Röpcke G
Zentralbl Gynakol; 1987; 109(5):265-73. PubMed ID: 3591061
[TBL] [Abstract][Full Text] [Related]
2. [Tumor markers (alpha 2-macroglobulin, secretory immunoglobulin A, pregnancy-associated alpha 2-glycoprotein) in the serum of patients with bronchial carcinoma].
Briese V; Willroth PO; Brock J; Straube W
Arch Geschwulstforsch; 1984; 54(5):391-8. PubMed ID: 6208875
[TBL] [Abstract][Full Text] [Related]
3. [Pregnancy protein-1 in the serum of patients with diseases of the breast].
Strache RR; Briese V; Szabo DG; Than GN; Kunze M; Richter D
Zentralbl Gynakol; 1987; 109(5):274-9. PubMed ID: 3035827
[TBL] [Abstract][Full Text] [Related]
4. [Levels of tumor markers (orosomucoid, pregnancy-associated alpha 2-glycoprotein, pregnancy protein-1, placental specific-tissue protein 10, placental specific-tissue protein 12, alpha 1-fetoprotein) in the serum of patients with bronchial carcinoma].
Briese V; Szabo DG; Than GN; Willroth PO; Straube W
Arch Geschwulstforsch; 1986; 56(1):13-22. PubMed ID: 2421681
[TBL] [Abstract][Full Text] [Related]
5. [Quantitative determination of secretory immunoglobulin A in the serum of patients with gynecologic tumors].
Briese V; Straube W; Brock J; Lorenz U
Zentralbl Gynakol; 1983; 105(21):1368-73. PubMed ID: 6659748
[TBL] [Abstract][Full Text] [Related]
6. Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.
Shimizu Y; Oshima K; Nakano Y; Fujita M; Taguchi T
Biken J; 1981 Sep; 24(3):95-102. PubMed ID: 6175310
[TBL] [Abstract][Full Text] [Related]
7. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immune complexes and immunologic reactivity in breast cancer].
Bilynskiĭ BT; Loginskiĭ VE; Fetsich TG
Eksp Onkol; 1984; 6(3):50-2. PubMed ID: 6333978
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes (CIC) as tumor marker in the follow-up of breast cancer.
Neri B; Comparini T; Ciatto S; Cataliotti L; Distante V; Bartalucci S
Cancer Detect Prev; 1985; 8(1-2):53-6. PubMed ID: 4064052
[TBL] [Abstract][Full Text] [Related]
10. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
[TBL] [Abstract][Full Text] [Related]
11. Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.
Stacker SA; Thompson CH; Lowe MG; Sacks NP; Golder J; Carmen H; McKenzie IF
Dev Biol Stand; 1987; 67():91-6. PubMed ID: 3609486
[TBL] [Abstract][Full Text] [Related]
12. [Value of interleukin-8 determination in diagnosis of benign and malignant breast tumor].
Zakrzewska I; Kozłowski L; Wojtukiewicz M
Pol Merkur Lekarski; 2002 Oct; 13(76):302-4. PubMed ID: 12557436
[TBL] [Abstract][Full Text] [Related]
13. Serum concentration of secretory IgA during pregnancy and in gynaecological diseases affecting glands and mucosas.
Briese V; Seyfarth M; Brock J
Zentralbl Gynakol; 1991; 113(18):987-94. PubMed ID: 1750298
[TBL] [Abstract][Full Text] [Related]
14. The presence and structure of circulating immune complexes in patients with prostate tumors.
Gołda R; Wolski Z; Wyszomirska-Gołda M; Madaliński K; Michałkiewicz J
Med Sci Monit; 2004 Mar; 10(3):CR123-7. PubMed ID: 14976452
[TBL] [Abstract][Full Text] [Related]
15. A comparison of IgA in portal and peripheral venous blood.
Challacombe SJ; Greenall C; Stoker TA
Immunology; 1987 Jan; 60(1):111-6. PubMed ID: 3817864
[TBL] [Abstract][Full Text] [Related]
16. Humoral immunity in Nigerians with Schistosoma haematobium infection.
Arinola OG; Salimonu LS
West Afr J Med; 1999; 18(4):275-80. PubMed ID: 10734791
[TBL] [Abstract][Full Text] [Related]
17. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women.
Romppanen J; Keskikuru R; Kataja V; Eskelinen M; Kosma VM; Savolainen K; Uusitupa M; Mononen I
Br J Cancer; 1999 Mar; 79(9-10):1583-7. PubMed ID: 10188910
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin classes, complement factors and circulating immune complexes in chronic sinusitis patients.
Ogunleye AO; Arinola OG
Afr J Med Med Sci; 2001 Dec; 30(4):309-12. PubMed ID: 14510109
[TBL] [Abstract][Full Text] [Related]
19. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
Salinas FA; Wee KH; Ceriani RL
Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
[TBL] [Abstract][Full Text] [Related]
20. Clinical evidence of secretory IgA and Schwangerschaftsprotein 1 in pleural effusions of lung cancer patients.
Briese V; Brock J; Willroth PO; Szabo DG; Than GN; Richter D
Arch Geschwulstforsch; 1988; 58(3):169-74. PubMed ID: 2458082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
